by Instem Team | Feb 23, 2026 | In Silico & Data Insights, Leadscope, Regulatory Submission
My Thoughts on NAMs and the Future of Drug Development: Progress Demands Leadership Donna Robinson, Chief Commercial Officer, Instem New ideas, methods, and technologies appear all the time, especially in the biomedical space. While the hype is often well-earned, many...
by Instem Team | Feb 20, 2026 | Resources
Preclinical research teams face growing pressure to deliver complete, traceable, and inspection‑ready data across both GLP studies and day‑to‑day colony operations. Yet many organizations still manage these domains separately, using solutions like Provantis® for...
by Instem Team | Jan 28, 2026 | Clinical, Company News, Press Releases
We are excited to announce the revival of the d-wise brand to represent Instem’s Clinical Trial Analytics and Transparency offerings. This movement returns our clinical portfolio to its roots while reinforcing our dedication to supporting and enriching the clinical...
by Instem Team | Jan 27, 2026 | Lab Execution, Matrix Gemini
The Benefits of a Dedicated LIMS A one-size-fits-all laboratory information management system (LIMS) may look attractive at first. Lower upfront costs, fewer decisions. But in practice, labs almost always obtain more value, efficiency, and compliance assurance...
by Instem Team | Jan 27, 2026 | Lab Execution, Matrix Gemini
Veterinary laboratories need to deliver rapid, accurate, and cost-effective results. Given the quantity, diversity, and specificity of protocols and data that veterinary labs need to handle, many find that traditional data management tools, paper forms, spreadsheets,...
